• Coronavirus Europe, in check before a relentless second wave of coronavirus and the fear of a third

The Belgian Budget Minister,

Eva De Bleeker

, has revealed this Thursday the different secret prices of the vaccines that the European Commission (EC) has negotiated with the laboratories, a confidential list that she placed on Twitter and then deleted, acknowledging that it had been too transparent.

According to this list, published in different currencies according to each contract,

the price of the doses of the future vaccine of AstraZeneca-Oxford rises to 1.78 euros

, that of Johnson & Johnson reaches 6.9 euros, that of Sanofi-GSK at 7.56 euros and CureVac at 10 euros.

The dose of the BioNTech-Pfizer vaccine, which the European Medicines Agency (EMA) is expected to approve on Monday 21 and begin to distribute before the end of the year, would cost 12 euros and two doses per person are necessary.

The doses of the Moderna prototype, on whose conditional approval the EMA will pronounce on January 6, would amount to 14.6 euros.

The Belgian Government has budgeted a provision of 279,120,190 euros for vaccines, which will be distributed voluntarily and free of charge to the 11.6 million residents of that Central European country.

The European Commission, which in recent months has barely wanted to give details about the

negotiations with the pharmaceutical companies

, apart from announcing the agreements reached with different laboratories and the number of doses signed, has avoided confirming whether the prices revealed by the minister Belgian are those reflected in the contracts.

The Commission's chief spokesman,

Éric Mamer

, pointed out that confidentiality is part of the contracts with the laboratories and recalled that "the information on prices is available to the Member States, as part of the negotiations and will also be shared with Parliament. European".

"This confidentiality is in the interest of companies, without a doubt, but also in the public interest, in the interest of negotiations, the Commission and the Member States and European citizens because we want to reach fair agreements with the companies. different companies ", specified the spokesman for Health of the EC,

Stefan de Keersmaecker

.

"If this information were made public, it would weaken the negotiating position of the Commission," he added.

For her part, the Belgian minister, from the Flemish liberal party Open Vld, deleted the list she had released and apologized for having revealed that information that had been jealously guarded for months.

"I was sleeping when they called me after spending 26-27 hours of debate here [in the federal Parliament]. As the discussion continued, I wanted to decide once and for all, perhaps too much," he said.

The Community Executive, which negotiates on behalf of the capitals, has built a varied portfolio with the six European and American pharmaceutical companies mentioned above, and is closing negotiations with a seventh, Novavax.

In case the EMA considers that all the prototypes are effective and safe,

the EU would have enough doses to vaccinate twice the 447 million European citizens and donate the surplus to neighboring countries

.

According to the criteria of The Trust Project

Know more

  • Coronavirus

  • Covid 19

  • European Union

  • European Comission

  • Belgium

The European Medicines Agency brings the meeting to evaluate Moderna's vaccine against Covid-19 until January 6

Coronavirus Christmas in pandemic: this is how our European neighbors will celebrate the holidays

The Pfizer-BioNTech vaccine will arrive guarded at 50 points in Spain from December 27

See links of interest

  • News

  • Programming

  • Translator

  • Work calendar

  • Films

  • Topics

  • Navalcarnero - CD Badajoz

  • Ribadumia - Cádiz

  • Anaitasuna - Getafe

  • AD San ​​Juan - Granada CF

  • Aston Villa - Burnley